ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Bioinformatics analysis combined with experimental validation to explore the mechanism of XianLing GuBao capsule against osteoarthritis

Xiao, Jiacong; Zhang, Gangyu; Mai, Jiale; He, Qi; Chen, Weijian; Li, Jianliang; Ma, Yanhuai; Pan, Zhaofeng; Yang, Junzheng; Li, Shaocong; Li, Miao; Chen, Bohao; Wang, Haibin*广州中医药大学; 1
Journal of Ethnopharmacology2022-8-10DOI: 10.1016/j.jep.2022.115292
5被引15阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: XianLing GuBao Capsule (XLGB) is often used to treat osteoarthritis (OA), osteoporosis, fractures, and other musculoskeleton disorders. However, the molecular mechanism of XLGB for treating OA is still unclear. Aim of the study: This study set out to uncover the molecular mechanism underlying the treatment of osteoarthritis with XLGB. Materials and methods: Disease genes were obtained from CTD, DisGeNET, and GeneCards databases, and XLGB drug targets were obtained from ETCM and target genes predicted by XLGB metabolic components reported in the literature. Then we used the Venn diagram viewer to extract disease and drug intersection genes as potential therapeutic genes for Protein-protein interaction (PPI), GO terminology, and KEGG pathway analysis. Subsequently, we performed qRT-PCR, Western blot and histological analysis to validate the therapeutic effect of XLGB against OA and its molecular mechanism. Results: A total of 1039 OA genes and 949 XLGB target genes were collected, and finally 188 potential therapeutic target genes were obtained. PPI network analysis indicated that the main target genes for XLGB to treat OA include Akt1, Mapk3, Il-6, Il-1 beta, Ptgs2, Mmp9, etc. The results of KEGG and GO enrichment analysis suggested that XLGB may treat OA by anti-inflammatory and reducing extracellular matrix degradation. In vitro, XLGB down regulated the expressions of Mmp3, Mmp9, Mmp12, Mmp13, Cox-2, Il-6, increased the expression of Collagen II and Sox9. Mechanistically, XLGB inhibits the activation of PI3K/AKT/NF-kappa B and MAPK pathways. Moreover, the results of animal experiments indicated that XLGB reduced cartilage destruction, bone resorption, and synovitis in osteoarthritic rats. Conclusions: XLGB has a protective effect against OA by suppressing PI3K/AKT/NF-kappa B and MAPK signaling. Our study provides a theoretical basis for XLGB in the treatment of osteoarthritis.

学科与关键词

关键词
XianLing GuBao capsulePI3K/AKT/NF-?B pathwayMAPK pathwayOsteoarthritisBioinformatics analysis
相关
加载中…
  • Network Pharmacology-Based Analysis on the Effects and Mechanism of the Wang-Bi Capsule for Rheumatoid Arthritis and Osteoarthritis
    Wu, Shan-Shan; Hao, Li-Jun; Shi, Yuan-Yuan; Lu, Zhuo-Jian; Yu, Jia-Lin; Jiang, Si-Qi; Liu, Qing-Ling; Wang, Ting*; Guo, Shi-Ying*; Li, Ping*; Li, Fei*ACS OMEGA, 2022, 7(9): 7825-7836.被引 6
  • Identification and validation of hub genes and potential drugs involved in osteoarthritis through bioinformatics analysis
    Xu, Wenbo; Wang, Xuyao; Liu, Donghui; Lin, Xin; Wang, Bo; Xi, Chunyang; Kong, Pengyu*; Yan, Jinglong*Frontiers in Genetics, 2023, 14: 1117713.被引 5
  • Tongbi Huoluo Decoction alleviates cartilage degeneration in knee osteoarthritis by inhibiting degradation of extracellular matrix
    Chen, Weijian; Liu, Weinian; Jiang, Tao; Liu, Lingyun; He, Qi; Lin, Tianye; Zhang, Jiayuan; Huo, Liwei; Xu, Xuemeng; Wang, Haibin*; Liang, Du*; Liu, WengangChinese Medicine, 2023, 18(1): 91.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2022-08-10
卷期
第 294 卷
页码
115292
DOI
10.1016/j.jep.2022.115292
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foun-dation of China [81774339, 82074462]

作者

  • X

    Xiao, Jiacong (第一作者)

    guangzhou univ chinese med · 1

  • Z

    Zhang, Gangyu

    guangzhou univ chinese med · 1

查看全部 13 位作者收起作者
  • M

    Mai, Jiale

    guangzhou univ chinese med · 1

  • H

    He, Qi

    guangzhou univ chinese med · 1

  • C

    Chen, Weijian

    guangzhou univ chinese med · 1

  • L

    Li, Jianliang

    guangzhou univ chinese med · 1

  • M

    Ma, Yanhuai

    guangzhou univ chinese med · 1

  • P

    Pan, Zhaofeng

    guangzhou univ chinese med · 1

  • Y

    Yang, Junzheng

    guangzhou univ chinese med · 1

  • L

    Li, Shaocong

    guangzhou univ chinese med · 1

  • L

    Li, Miao

    guangzhou univ chinese med · 1

  • C

    Chen, Bohao

    guangzhou univ chinese med · 1

  • W

    Wang, Haibin (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417